Cargando…
The future of artemisinins: natural, synthetic or recombinant?
Artemisinins are the most important anti-malarial drugs in use today, but are more costly than previous anti-malarials and production and price tend to fluctuate. Alternative ways of producing artemisinins are discussed here in the light of a recent paper in BMC Biotechnology on improving the yield...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776395/ https://www.ncbi.nlm.nih.gov/pubmed/19090980 http://dx.doi.org/10.1186/jbiol101 |
| _version_ | 1782174093945077760 |
|---|---|
| author | Hommel, Marcel |
| author_facet | Hommel, Marcel |
| author_sort | Hommel, Marcel |
| collection | PubMed |
| description | Artemisinins are the most important anti-malarial drugs in use today, but are more costly than previous anti-malarials and production and price tend to fluctuate. Alternative ways of producing artemisinins are discussed here in the light of a recent paper in BMC Biotechnology on improving the yield of the precursor, artemisinic acid, in genetically engineered yeast. |
| format | Text |
| id | pubmed-2776395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27763952009-11-13 The future of artemisinins: natural, synthetic or recombinant? Hommel, Marcel J Biol Minireview Artemisinins are the most important anti-malarial drugs in use today, but are more costly than previous anti-malarials and production and price tend to fluctuate. Alternative ways of producing artemisinins are discussed here in the light of a recent paper in BMC Biotechnology on improving the yield of the precursor, artemisinic acid, in genetically engineered yeast. BioMed Central 2008 2008-12-15 /pmc/articles/PMC2776395/ /pubmed/19090980 http://dx.doi.org/10.1186/jbiol101 Text en Copyright © 2008 BioMed Central Ltd |
| spellingShingle | Minireview Hommel, Marcel The future of artemisinins: natural, synthetic or recombinant? |
| title | The future of artemisinins: natural, synthetic or recombinant? |
| title_full | The future of artemisinins: natural, synthetic or recombinant? |
| title_fullStr | The future of artemisinins: natural, synthetic or recombinant? |
| title_full_unstemmed | The future of artemisinins: natural, synthetic or recombinant? |
| title_short | The future of artemisinins: natural, synthetic or recombinant? |
| title_sort | future of artemisinins: natural, synthetic or recombinant? |
| topic | Minireview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776395/ https://www.ncbi.nlm.nih.gov/pubmed/19090980 http://dx.doi.org/10.1186/jbiol101 |
| work_keys_str_mv | AT hommelmarcel thefutureofartemisininsnaturalsyntheticorrecombinant AT hommelmarcel futureofartemisininsnaturalsyntheticorrecombinant |